Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Sales | 2,795 | 3,690 | 5,646 | 4,008 | 6,605 |
| Gross Profit | 2,795 | 3,690 | 5,646 | 4,008 | 6,605 |
| Operating Expenses | 17,737 | 19,730 | 20,289 | 18,545 | 23,486 |
| Operating Income | -14,942 | -16,040 | -14,643 | -14,537 | -16,881 |
| Interest Expense | 88 | 104 | 123 | 136 | 149 |
| Other Income | 26 | 60 | 77 | 27 | 258 |
| Pre-tax Income | -15,004 | -16,084 | -14,689 | -14,646 | -16,772 |
| Net Income Continuous | -15,004 | -16,084 | -14,689 | -14,646 | -16,772 |
| Net Income | $-15,004 | $-16,084 | $-14,689 | $-14,646 | $-16,772 |
| EPS Basic Total Ops | -0.34 | -0.37 | -0.33 | -0.38 | -0.43 |
| EPS Basic Continuous Ops | -0.34 | -0.37 | -0.33 | -0.38 | -0.43 |
| EPS Diluted Total Ops | -0.34 | -0.37 | -0.33 | -0.38 | -0.43 |
| EPS Diluted Continuous Ops | -0.34 | -0.37 | -0.33 | -0.38 | -0.43 |
| EBITDA(a) | $-13,554 | $-14,497 | $-13,080 | $-13,337 | $-15,823 |